We’re excited to share the story of the discovery and early clinical development of JNT-517, our oral small molecule drug candidate being evaluated in PKU, in the peer-reviewed journal JCI Insight. Find the publication here: https://bit.ly/3D2qDR4. Thanks to our team for their work on this publication!
Jnana Therapeutics This will be a lifechanging innovation for the #PKU communities congrats egoo.health
Congrats!